Maze Therapeutics, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
MAZE
Maze Therapeutics, Inc. Common Stock
$28.38 +26.75%
VS TWSTTwist Bioscience Corporation Common Stock
$164.60 -0.74%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| MAZE | TWST | |
|---|---|---|
| Market Cap | $1.24 billion | $10.99 billion |
| Revenue (TTM) | $20.00 million | $431.80 million |
| Net Income (TTM) | $-133,590,000 | $-136,717,000 |
TWST leads on 2 of 3 size & scale factors.
Valuation
| MAZE | TWST | |
|---|---|---|
| Price / Book | 2.74 | 24.67 |
| Price / Sales | 62.19 | 25.46 |
MAZE and TWST split the valuation factors evenly.
Profitability
| MAZE | TWST | |
|---|---|---|
| Net Margin | -667.95% | -31.66% |
| Return on Equity | -29.48% | -30.67% |
MAZE and TWST split the profitability factors evenly.
Risk & Sentiment
| MAZE | TWST | |
|---|---|---|
| Short Interest | 2.15% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: MAZE overview, MAZE financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.